Brief: China Regenerative Medicine says Dai Yumin acquired 21.6 mln ordinary shares of co
04/02/2016 10:08
Feb 4 (Reuters) - China Regenerative Medicine International Ltd 8158.HK : * Crmi-voluntary announcement increase in shareholding by substantial shareholder 8158.HK * Dai Yumin an executive director, acquired 21.6 million ordinary shares of the company * Source text for Eikon ID:nHKS9SMx9z ((For more news, please click here 8158.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital